Molecular & Cellular Oncology (May 2018)

LPCAT2 controls chemoresistance in colorectal cancer

  • Alexia Karen Cotte,
  • Virginie Aires,
  • François Ghiringhelli,
  • Dominique Delmas

DOI
https://doi.org/10.1080/23723556.2018.1448245
Journal volume & issue
Vol. 5, no. 3

Abstract

Read online

Lipid droplets (LD) are now-well recognized as playing a role in cancer progression, however their potential role in chemoresistance remains largely unknown, particularly in colorectal cancer (CRC). We recently highlighted that LD accumulate in CRC cells under the control of lysophosphatidylcholine acyltransferase 2 (LPCAT2) enzyme expression. We also showed that chemotherapy-induced LD accumulation counteracts intrinsic and extrinsic cancer cell death activation.

Keywords